应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XENE Xenon制药
已收盘 07-23 16:00:00 EDT
43.78
+0.66
+1.53%
盘后
43.78
+0.00
0.00%
19:43 EDT
最高
43.95
最低
42.48
成交量
46.44万
今开
43.13
昨收
43.12
日振幅
3.41%
总市值
33.04亿
流通市值
30.51亿
总股本
7,547万
成交额
2,015万
换手率
0.67%
流通股本
6,970万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Xenon制药盘中异动 下午盘大幅上涨5.08%报39.08美元
自选股智能写手 · 07-10
Xenon制药盘中异动 下午盘大幅上涨5.08%报39.08美元
Xenon制药2024财年第一财季实现净利润-47.93百万美元,同比减少14.86%
自选股智能写手 · 05-19
Xenon制药2024财年第一财季实现净利润-47.93百万美元,同比减少14.86%
花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。
智通财经 · 05-11
花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。
Xenon制药盘中异动 早盘股价大跌6.86%
自选股智能写手 · 05-10
Xenon制药盘中异动 早盘股价大跌6.86%
Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。
智通财经 · 05-10
Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。
Xenon制药盘中异动 下午盘股价大涨5.02%
自选股智能写手 · 04-30
Xenon制药盘中异动 下午盘股价大涨5.02%
Xenon制药盘中异动 下午盘快速跳水5.05%报40.80美元
自选股智能写手 · 04-13
Xenon制药盘中异动 下午盘快速跳水5.05%报40.80美元
Xenon制药2023财年实现净利润-1.82亿美元,同比减少45.60%
自选股智能写手 · 03-09
Xenon制药2023财年实现净利润-1.82亿美元,同比减少45.60%
Xenon制药盘中异动 早盘股价大涨5.17%报49.64美元
自选股智能写手 · 03-01
Xenon制药盘中异动 早盘股价大涨5.17%报49.64美元
公司概况
公司名称:
Xenon制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。
发行价格:
--
{"stockData":{"symbol":"XENE","market":"US","secType":"STK","nameCN":"Xenon制药","latestPrice":43.78,"timestamp":1721764800000,"preClose":43.12,"halted":0,"volume":464361,"hourTrading":{"tag":"盘后","latestPrice":43.78,"preClose":43.78,"latestTime":"19:43 EDT","volume":25840,"amount":1131275.2,"timestamp":1721778191919},"delay":0,"floatShares":69697143,"shares":75468883,"eps":-2.699777,"marketStatus":"已收盘","marketStatusCode":5,"change":0.66,"latestTime":"07-23 16:00:00 EDT","open":43.13,"high":43.95,"low":42.48,"amount":20150634.47313,"amplitude":0.034091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.699777,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721808000000},"adr":0,"listingDate":1415163600000,"adjPreClose":43.12,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":43.78,"preClose":43.78,"latestTime":"19:43 EDT","volume":25840,"amount":1131275.2,"timestamp":1721778191919},"volumeRatio":1.199922,"impliedVol":0.5087,"impliedVolPercentile":0.254},"requestUrl":"/m/hq/s/XENE/wiki","defaultTab":"wiki","newsList":[{"id":"2450020073","title":"Xenon制药盘中异动 下午盘大幅上涨5.08%报39.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450020073","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450020073?lang=zh_cn&edition=full","pubTime":"2024-07-10 01:27","pubTimestamp":1720546043,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日01时27分,Xenon制药股票出现波动,股价大幅上涨5.08%。截至发稿,该股报39.08美元/股,成交量11.9662万股,换手率0.16%,振幅5.59%。Xenon制药股票所在的生物技术行业中,整体跌幅为0.26%。其相关个股中,Soligenix, Inc.、180 Life Sciences Corp.、Uniqure N.V.涨幅较大,Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃,换手率分别为11400.00%、2757.65%、340.29%,振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为468.99%、196.29%、134.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710012723af916068&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710012723af916068&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2436621181","title":"Xenon制药2024财年第一财季实现净利润-47.93百万美元,同比减少14.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436621181","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436621181?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:16","pubTimestamp":1716049011,"startTime":"0","endTime":"0","summary":"3月31日,Xenon制药公布财报,公告显示公司2024财年第一财季净利润为-47.93百万美元,同比减少14.86%;其中营业收入为0.00美元,每股基本收益为-0.62美元。从资产负债表来看,Xenon制药总负债31.33百万美元,其中短期债务1.32百万美元,资产负债比为0.30,流动比率为0.32。机构评级:截至2024年3月31日,当前有15家机构对Xenon制药目标价做出预测,其中目标均价为58.13美元,其中最低目标价为50.00美元,最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017028b15ebdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017028b15ebdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2434897635","title":"花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434897635","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434897635?lang=zh_cn&edition=full","pubTime":"2024-05-11 05:45","pubTimestamp":1715377502,"startTime":"0","endTime":"0","summary":"花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110545068af27159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110545068af27159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2434854677","title":"Xenon制药盘中异动 早盘股价大跌6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854677","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434854677?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:31","pubTimestamp":1715347896,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时31分,Xenon制药股票出现异动,股价急速跳水6.86%。截至发稿,该股报39.58美元/股,成交量5703股,换手率0.01%,振幅0.89%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.15%。Xenon制药公司简介:Xenon Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发治疗方法,以改善神经系统疾病患者的生活,包括罕见的中枢神经系统疾病。该信息摘要如下:Wedbush:维持Xenon Pharmaceuticals评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213136792706bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213136792706bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2434674854","title":"Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434674854","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434674854?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:26","pubTimestamp":1715347607,"startTime":"0","endTime":"0","summary":"Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102126538750f2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102126538750f2d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2431115508","title":"Xenon制药盘中异动 下午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431115508","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431115508?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:32","pubTimestamp":1714411976,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时32分,Xenon制药股票出现异动,股价大幅拉升5.02%。截至发稿,该股报42.54美元/股,成交量26.4466万股,换手率0.35%,振幅4.75%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.86%。其相关个股中,Calidi Biotherapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Zura Bio Limited C/Wts 涨幅较大,Zyversa Therapeutics, Inc.、Annovis Bio, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为1001.06%、61.38%、59.60%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为98.32%、79.12%、75.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300132567a574c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300132567a574c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XENE"],"gpt_icon":0},{"id":"2427751728","title":"Xenon制药盘中异动 下午盘快速跳水5.05%报40.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427751728","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427751728?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:13","pubTimestamp":1712949203,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时13分,Xenon制药股票出现异动,股价快速跳水5.05%。截至发稿,该股报40.80美元/股,成交量40.9531万股,换手率0.54%,振幅4.47%。Xenon制药股票所在的生物技术行业中,整体跌幅为1.59%。Xenon制药公司简介:Xenon Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发创新疗法以改善患有神经系统疾病的患者的生活。消息层面,截至03时13分,Xenon制药股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413031324792040c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413031324792040c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE","BK4139"],"gpt_icon":0},{"id":"2418061944","title":"Xenon制药2023财年实现净利润-1.82亿美元,同比减少45.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418061944","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418061944?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:18","pubTimestamp":1709914722,"startTime":"0","endTime":"0","summary":"12月31日,Xenon制药公布财报,公告显示公司2023财年净利润为-1.82亿美元,同比减少45.60%;其中营业收入为0.00美元,每股基本收益为-2.73美元。从资产负债表来看,Xenon制药总负债36.88百万美元,其中短期债务1.30百万美元,资产负债比为0.27,流动比率为0.24。机构评级:截至2023年12月31日,当前有15家机构对Xenon制药目标价做出预测,其中目标均价为58.33美元,其中最低目标价为50.00美元,最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090018548b18f330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090018548b18f330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XENE"],"gpt_icon":0},{"id":"2416641802","title":"Xenon制药盘中异动 早盘股价大涨5.17%报49.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416641802","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416641802?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:31","pubTimestamp":1709303509,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时31分,Xenon制药股票出现异动,股价急速上涨5.17%。截至发稿,该股报49.64美元/股,成交量1.2515万股,换手率0.02%,振幅4.53%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.86%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃,换手率分别为947.58%、112.63%、63.93%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Biovie Inc.,振幅分别为29.41%、25.14%、22.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122314987d7ec9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122314987d7ec9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XENE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xenon-pharma.com","stockEarnings":[{"period":"1week","weight":0.0291},{"period":"1month","weight":0.1502},{"period":"3month","weight":0.0494},{"period":"6month","weight":-0.0207},{"period":"1year","weight":0.1651},{"period":"ytd","weight":-0.0638}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.016498},{"month":2,"riseRate":0.8,"avgChangeRate":0.093266},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073532},{"month":4,"riseRate":0.5,"avgChangeRate":0.011324},{"month":5,"riseRate":0.4,"avgChangeRate":-0.016681},{"month":6,"riseRate":0.4,"avgChangeRate":0.027028},{"month":7,"riseRate":0.4,"avgChangeRate":0.023445},{"month":8,"riseRate":0.777778,"avgChangeRate":0.069179},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.073402},{"month":10,"riseRate":0.333333,"avgChangeRate":0.057348},{"month":11,"riseRate":0.666667,"avgChangeRate":0.050085},{"month":12,"riseRate":0.7,"avgChangeRate":0.115516}],"exchange":"NASDAQ","name":"Xenon制药","nameEN":"Xenon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xenon制药,XENE,Xenon制药股票,Xenon制药股票老虎,Xenon制药股票老虎国际,Xenon制药行情,Xenon制药股票行情,Xenon制药股价,Xenon制药股市,Xenon制药股票价格,Xenon制药股票交易,Xenon制药股票购买,Xenon制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}